North America Joint Pain Injection Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Drugs (Hyaluronic Acid, Corticosteroid, and Others), Joint Type (Knee, Foot and Ankle, Shoulder and Elbow, Hip, and Others), and Distribution Channel (Retail Pharmacies, Hospitals Pharmacies, and Others)
Market Introduction
The North America joint pain injection market is a highly fragmented market with the presence of considerable regional and local players providing numerous solutions for companies investing in the market arena. Hyaluronic acid injections offered by companies are usually administered for treating sports injuries, as they aid in pain relief, reduce inflammation, and improve joint function. Corticosteroids are also used to treat sports-related injuries. Sports injuries are caused due to direct impact, or the application of force that is larger than the body part can withstand. The most common sport injuries are sprains, strains, joint injuries, and bruises. As per the National Safety Council (NSC), in 2019, exercise accounted for ~468,000 injuries in the US, the most of any category of sports and recreation. People involved in football, bicycling, basketball, playground, and soccer activities contributed to the highest number of emergency department (ED) visits in that year. It also states sport injuries affect over thousands of youth population engaged in various sports.
In North America, especially the US witnessed an unprecedented rise in the number of COVID-19 cases, which led to the discontinuation of several business operations and manufacturing activities of various healthcare products, including joint pain injections, which negatively impacted the joint pain injection market. In order to manage the outbreak, government took preventive measures including total lockdowns and social distancing policies. In addition, medical device industry is also facing negative impact of this pandemic. As the COVID-19 pandemic continues to unfold, medical device companies are finding difficulties in managing their operations. Cancelling elective surgeries to reduce exposure to COVID-19 in the hospital and operating rooms into intensive care units is also negatively affecting the growth of the joint pain injection market. However, at end of second quarter, restrictions on orthopedic procedures were lifted by the US government and patients were also allowed to visit orthopedic offices. Such decisions helped market players to recover their losses during the pandemic.
Get more information on this report :
Market Overview and Dynamics
The joint pain injection market in North America is expected to grow from US$ 2,785.42 million in 2021 to US$ 5,010.47 million by 2028; it is estimated to grow at a CAGR of 8.7% from 2021 to 2028. Countries in North America are emerging as attractive outsourcing locations for pharmaceuticals and biopharmaceuticals industries. Flourishing domestic pharmaceutical market and increasing number of pipeline drugs are further opening new avenues for the contract manufacturers as well as generic drug manufacturing in the region. Additionally, to meet the growing demand, many contract-based organizations are expanding their manufacturing capabilities. Thus, the emerging markets hold high potential and huge revenue generation opportunities for the pharmaceutical manufacturing companies. According to a report published by the US Department of Health & Human Services in the year 2018 stated that near 700,000 knee replacement surgeries in US are being carried out every year. It is also expected that the number is likely to reach approximately 3.48 million surgeries per year till 2030. Other than the knee surgeries, the incidences of the hip replacement surgeries are also increasing in the ageing population. As per the Agency for Healthcare Research and Quality, over 450,000 total hip replacements are performed every year in the United States. Furthermore, as per the report published in The Journal of Rheumatology in the year 2018, stated that in US incidence of total hip replacement surgeries are expected to increase by 129% in 2030 which is around 850,000 replacements procedures and by 284% in 2040 that is about 1,429,000 replacements. The advancement is the technology has led into the reduction of the time for the surgeries.
Key Market Segments
Based on drugs, the corticosteroid segment accounted for the largest share of the North America joint pain injection market in 2020. Based on joint type, the knee segment accounted for the largest share of the North America joint pain injection market in 2020. Based on distribution channel, the hospitals pharmacies segment accounted for the largest share of the North America joint pain injection market in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the North America joint pain injection market are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report include Chugai Pharmaceutical Co., Ltd.; Bioventus Inc.; Fidia Pharma USA Inc.; Flexion Therapeutics, Inc.; Seikagaku Corporation; Ferring B.V.; Sanofi; Anika Therapeutics, Inc; OrthogenRx, Inc. and Teva Pharmaceutical Industries Ltd.
Reasons to buy report
- To understand the North America joint pain injection market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for North America joint pain injection market
- Efficiently plan M&A and partnership deals in North America joint pain injection market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form North America joint pain injection market
- Obtain market revenue forecast for market by various segments from 2020-2028 in North America region.
North America Joint Pain Injection Market Segmentation
North America Joint Pain Injection Market -By Drugs
- Hyaluronic Acid
- Corticosteroid
- Others
North America Joint Pain Injection Market -By Joint Type
- Knee
- Foot and Ankle
- Shoulder and Elbow
- Hip
- Others
North America Joint Pain Injection Market -By Distribution Channel
- Retail Pharmacies
- Hospitals Pharmacies
- Others
North America Joint Pain Injection Market – By Country
- US
- Canada
- Mexico
North America Joint Pain Injection Market – Company Profiles
- Chugai Pharmaceutical Co., Ltd.
- Bioventus Inc.
- Fidia Pharma USA Inc.
- Flexion Therapeutics, Inc.
- Seikagaku Corporation
- Ferring B.V.
- Sanofi
- Anika Therapeutics, Inc.
- OrthogenRx, Inc.
- Teva Pharmaceutical Industries Ltd.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Joint Pain Injection Market – By Drugs
1.3.2 North America Joint Pain Injection Market – By Joint Type
1.3.3 North America Joint Pain Injection Market – By Distribution Channel
1.3.4 North America Joint Pain Injection Market – By Country
2. North America Joint Pain Injection Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Joint Pain Injection – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Expert Opinions
5. Joint Pain Injection Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 High Prevalence of Musculoskeletal Disorders
5.1.2 Increasing Number of Sports Injuries
5.2 Market Restraints
5.2.1 High Costs of Joint Repair Therapies
5.3 Market Opportunities
5.3.1 Proliferation of Pharmaceutical Sector in Emerging Markets
5.4 Future Trends
5.4.1 Product Innovations
5.5 Impact Analysis
6. Joint Pain Injection Market – North America Analysis
6.1 North America Joint Pain Injection Market Revenue Forecast and Analysis
6.2 North America Joint Pain Injection Market, By Country - Forecast and Analysis
7. North America Joint Pain Injection Market Analysis – By Drugs
7.1 Overview
7.2 Joint Pain Injection Market Revenue Share, by Drugs (2020 and 2028)
7.3 Hyaluronic Acid
7.3.1 Overview
7.3.2 Hyaluronic Acid: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Corticosteroid
7.4.1 Overview
7.4.2 Corticosteroid: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
8. North America Joint Pain Injection Market Analysis – By Joint Type
8.1 Overview
8.2 Joint Pain Injection Market Revenue Share, by Joint Type (2020 and 2028)
8.3 Knee
8.3.1 Overview
8.3.2 Knee: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Hip
8.4.1 Overview
8.4.2 Hip: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Foot and Ankle
8.5.1 Overview
8.5.2 Foot and Ankle: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Shoulder and Elbow
8.6.1 Overview
8.6.2 Shoulder and Elbow: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Joint Pain Injection Market Analysis – By Distribution Channel
9.1 Overview
9.2 Joint Pain Injection Market Share, by Distribution Channel, 2020 and 2028, (%)
9.3 Hospitals Pharmacies
9.3.1 Overview
9.3.2 Hospitals Pharmacies: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Retail Pharmacies
9.4.1 Overview
9.4.2 Retail Pharmacies: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
10. North America Joint Pain Injection Market – Country Analysis
10.1 North America: Joint Pain Injection Market Revenue and Forecast to 2028
10.1.1 Overview
10.1.2 North America: Joint Pain Injection Market, by Country, 2020 & 2028 (%)
10.1.3 US: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.1.3.1 US: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.1.3.2 US: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)
10.1.3.3 US: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)
10.1.3.4 US: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)
10.1.4 Canada: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.1.4.1 Canada: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.1.4.2 Canada: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)
10.1.4.3 Canada: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)
10.1.4.4 Canada: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)
10.1.5 Mexico: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.1.5.1 Mexico: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.1.5.2 Mexico: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)
10.1.5.3 Mexico: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)
10.1.5.4 Mexico: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)
11. Impact of COVID-19 Pandemic on North America Joint Pain Injection Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. North America Joint Pain Injection Market – Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 Chugai Pharmaceutical Co., Ltd.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Bioventus Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Fidia Pharma USA Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Flexion Therapeutics, Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Seikagaku Corporation
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Ferring B.V.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Sanofi
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Anika Therapeutics, Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 OrthogenRx, Inc.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Teva Pharmaceutical Industries Ltd.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms\
LIST OF TABLES
Table 1. North America Joint Pain Injection Market –Revenue and Forecast To 2028 (US$ Million)
Table 2. US Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)
Table 3. US Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)
Table 4. US Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 5. Canada Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)
Table 6. Canada Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)
Table 7. Canada Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 8. Mexico Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)
Table 9. Mexico Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)
Table 10. Mexico Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 11. Organic Developments Done By Companies
Table 12. Inorganic Developments Done by Companies
Table 13. Glossary of Terms, Joint Pain Injection Market
LIST OF FIGURES
Figure 1. Joint Pain Injection Market Segmentation
Figure 2. North America Joint Pain Injection Market Segmentation, By Country
Figure 3. Joint Pain Injection Market Overview
Figure 4. Knee Joint Type Segment Held Largest Share of Joint Pain Injection Market
Figure 5. US to Show Significant Growth During Forecast Period
Figure 6. North America Joint Pain Injection Market, Industry Landscape
Figure 7. North America PEST Analysis
Figure 8. Number of Sports Injuries in US, 2019
Figure 9. Joint Pain Injection Market Impact Analysis of Driver and Restraints
Figure 10. North America Joint Pain Injection Market – Revenue Forecast and Analysis – 2020- 2028
Figure 11. Joint Pain Injection Market Revenue Share, by Drugs (2020 and 2028)
Figure 12. Hyaluronic Acid: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Corticosteroid: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Others: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Joint Pain Injection Market Revenue Share, by Joint Type (2020 and 2028)
Figure 16. Knee: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Hip: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Foot and Ankle: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Shoulder and Elbow: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Other: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Joint Pain Injection Market Share, by Distribution Channel, 2020 and 2028 (%)
Figure 22. Hospitals Pharmacies: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Retail Pharmacies: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Others: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. North America: Joint Pain Injection Market, by Key Country – Revenue (2020) (USD Million)
Figure 26. North America: Joint Pain Injection Market, by Country, 2020 & 2028 (%)
Figure 27. US: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
Figure 28. Canada: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
Figure 29. Mexico: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
Figure 30. Impact of COVID-19 Pandemic in North American Country Markets
Figure 31. Growth Strategies Done by the Companies in the Market, (%)
- Chugai Pharmaceutical Co., Ltd.
- Bioventus Inc.
- Fidia Pharma USA Inc.
- Flexion Therapeutics, Inc.
- Seikagaku Corporation
- Ferring B.V.
- Sanofi
- Anika Therapeutics, Inc.
- OrthogenRx, Inc.
- Teva Pharmaceutical Industries Ltd.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America joint pain injection market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America joint pain injection market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America joint pain injection market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution